Portfolio company
SepsiScan
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops bedside imaging devices for real-time microcirculation monitoring and early sepsis diagnosis for intensive care units and hospitals.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Advanced Perfusion Diagnostics
This company develops single-use devices for non-invasive, continuous microcirculation assessment and early sepsis detection for clinicians in critical care and surgical settings.
GlucoSet
The company develops an intravascular sensor that provides continuous blood glucose monitoring for critically ill patients in intensive care units.
Sencilia
This company develops non-invasive flow sensors for monitoring intravenous infusion therapy in neonatal and paediatric intensive care units.
Noninvasix
This company develops non-invasive optoacoustic monitoring technology to measure central venous oxygenation levels for clinicians treating patients with sepsis and septic shock.
Septest
This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.
CytoVale
This medical diagnostics company develops the IntelliSep test to provide rapid sepsis detection for hospital emergency departments and health systems.
Aisthesis Medical
The company develops artificial intelligence software that predicts sepsis and patient deterioration for hospitals and clinical teams.
CranioSense
This company develops non-invasive diagnostic systems to monitor intracranial pressure for emergency care teams and clinicians treating traumatic brain injuries.
